🔴 Prodia Diagnostic Line is trading 5.3% down today on post-IPO profit-taking and normalization

Prodia Diagnostic Line is trading 5.3% down at IDR 286 as the stock undergoes a period of normalization and follow-through selling following its recent market debut.

• The stock previously hit the Auto Reject Atas (ARA) limit on its July 9 IPO and rallied as high as the IDR 430–440 range before the current reversal.
• Current price action reflects ongoing profit-taking after sharp post-IPO swings rather than any new company-specific developments.
• Shares are continuing a string of declines as the market stabilizes from the initial volatility seen during the first weeks of trading.